Viva Physicians announces late-breaking clinical trial lineup

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Viva Physicians, a non-profit organization devoted to vascular interventions and medicine, announced the late-breaking clinical trials for its annual conference. The meeting will take place from September 18 to 22 in Las Vegas at the Wynn resort and casino.

Here are the titles of the late-breaking trials as well as the names of the presenters (all times are Pacific Standard Time):

September 19

8:31 a.m. – MOBILE Clinical Trial: Marrowtim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease – Michael P. Murphy, MD, FACS

8:43 a.m. – Safety and Performance of the Shockwave Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-phase DISRUPT PAD Study – Thomas Zeller, MD, FACS

8:55 a.m. – Results from the IN.PACT SFA Randomized Trial – Prakash Krishnan, MD

9:07 a.m. – VIRTUS US Iliofemoral Stenting IDE Trial – Stephen Black, MD

9:19 a.m. – Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort – Michael R. Jaff, DO

September 20

8:10 a.m. – Endovascular Repair in Acute, Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US-IDE Study – Ali Azizzadeh, MD

8:22 a.m. – Fast-Track Endovascular Aortic Repair: Final Results from the Prospective LIFE Registry – Zvonimir Krajcer, MD

8:34 a.m. – Arteriovenous Fistula (AVF) Post-Creation Interventions: a Comparison Between Traditional Surgical AVF Creation and a New Endovascular Approach – Charmaine Lok, MD, FRCPC

8:46 a.m. – MAJESTIC 2 Year Results Plus Sub-group Analysis – Stefan Müller-Hülsbeck, MD

8:58 a.m. – 2 Year Results of Paclitaxel Coated Balloons for Long Femoro-popliteal Artery Disease: Evidence from the SFA-Long Study – Antonio Micari, MD, PhD

September 21

9:10 a.m. – ESPRIT I Trial: Three-Year Results of The Evaluation of The ESPRIT Bioresorbable Vascular Scaffold (ESPRIT BVS) in The Treatment of Patients with Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries – Richard Rapoza, MD

9:22 a.m. – 12 Month Results from the DANCE Trial Atherectomy Cohort – Chris Owens, MD

9:34 a.m. – Use of an Expanded Polytetrafluoroethylene (ePTFE) Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery: Nine-Month Results from the Prospective, Multicenter BOLSTER Trial – John Laird, MD

9:44 a.m. – Carotid Stent Fractures are not associated with Restenosis, Stroke, Myocardial Infarction or Death: Results from the ACT 1 Multicenter Randomized Trial – Ido Weinberg, MD

9:54 a.m. – Novel Nitinol Stent for Long Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: 24 Month Results from the TIGRIS Randomized Trial – John Laird, MD

10:04 a.m. – PRISM Indigo Aspiration System as a Potential Frontline Tool for Vacuum-assisted Aspiration Thrombectomy in the Periphery – Richard Saxon, MD